Scotia Capital Inc. Enveric Biosciences, Inc. Transaction History

Scotia Capital Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$8.8 - $16.2 $6,089 - $11,210	-692 Reduced 2.54%	26,580 $6,000
Q1 2022 May 09, 2022	SELL	$12.5 - $52.0 $486,037 - $2.02 Million	-38,883 Reduced 58.78%	27,272 $9,000
Q4 2021 Feb 11, 2022	SELL	$46.5 - $104.0 $1.31 Million - $2.94 Million	-28,240 Reduced 29.92%	66,155 $62,000
Q3 2021 Nov 12, 2021	BUY	$80.5 - $175.0 $7.6 Million - $16.5 Million	94,395 New	94,395 $195,000

Ticker ENVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,078,270
Market Cap $1.04M
Description
Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for...

Get notified when there are updates to the investment portfolio of Scotia Capital Inc., based on Form 13F filings with the SEC.

Stay updated on Scotia Capital Inc. with notifications on news.